Page last updated: 2024-08-21

ethoglucid and Disease Exacerbation

ethoglucid has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ay, R; de Pauw, M; Debruyne, F; Kurth, K; Pavone-Macaluso, M; Schröder, FH; Sylvester, R; ten Kate, F; Tunn, U	1

Trials

1 trial(s) available for ethoglucid and Disease Exacerbation

Article	Year
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone. The Journal of urology, 1997, Volume: 158, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Disease Progression; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Time Factors; Urinary Bladder Neoplasms	1997

Article

Year

Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.

The Journal of urology, 1997, Volume: 158, Issue:2

Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Disease Progression; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Time Factors; Urinary Bladder Neoplasms

1997